| Literature DB >> 30835099 |
Ian Sinclair1, Martin Bachman1,2, Daniel Addison3, Mattias Rohman4, David C Murray1, Gareth Davies1, Elizabeth Mouchet1, Michael E Tonge3, Richard G Stearns5, Lucien Ghislain5, Sammy S Datwani5, Lars Majlof5, Eric Hall5, Gareth R Jones6, Emmy Hoyes6, Joe Olechno5, Richard N Ellson5, Perdita E Barran7, Steven D Pringle6, Michael R Morris6, Jonathan Wingfield3.
Abstract
Mass spectrometry (MS) has many advantages as a quantitative detection technology for applications within drug discovery. However, current methods of liquid sample introduction to a detector are slow and limit the use of mass spectrometry for kinetic and high-throughput applications. We present the development of an acoustic mist ionization (AMI) interface capable of contactless nanoliter-scale "infusion" of up to three individual samples per second into the mass detector. Installing simple plate handling automation allowed us to reach a throughput of 100 000 samples per day on a single mass spectrometer. We applied AMI-MS to identify inhibitors of a human histone deacetylase from AstraZeneca's collection of 2 million small molecules and measured their half-maximal inhibitory concentration. The speed, sensitivity, simplicity, robustness, and consumption of nanoliter volumes of sample suggest that this technology will have a major impact across many areas of basic and applied research.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30835099 DOI: 10.1021/acs.analchem.9b00142
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986